Hospira Inc. (NYSE:HSP) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are up 0.78%.
Hospira Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 7.84% to $0.55 in the quarter versus EPS of $0.51 in the year-earlier quarter.
Revenue: Decreased 0.69% to $1.03 billion from the year-earlier quarter.
Actual vs. Wall St. Expectations: Hospira Inc. reported adjusted EPS income of $0.55 per share. By that measure, the company beat the mean analyst estimate of $0.51. It missed the average revenue estimate of $1.03 billion.
Quoting Management: “Today’s announcement is confirmation that Inflectra has met the very rigorous quality, safety and efficacy requirements that have been established by the EMA, and provides the next step toward Inflectra being approved for use in Europe ,” said Dr. Stan Bukofzer , Corporate Vice President and Chief Medical Officer, Hospira.
Key Stats (on next page)…
Revenue decreased 0% from $0 in the previous quarter. EPS increased 5.77% from $0.52 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.45 and has not changed. For the current year, the average estimate is a profit of $2.03, which is the same with that ninety days ago.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)